<unk> (injection) is an antidote that is FDA approved for the treatment of after high-dose methotrexate therapy in osteosarcoma to diminish the toxicity and counteract the effects of impaired methotrexate and also indicated in the treatment of megaloblastic anemias due to folic acid deficiency.   Common adverse reactions include diarrhea, nausea, stomatitis, vomiting, fatigue, allergic reaction.
Leucovorin 
Levoleucovorin
Strontium ranelate
Darbepoetin Alfa
Deferoxamine
Edetate disodium
Indigotindisulfonate
Darbepoetin alfa